CMECME Group

$280.55+11% 1Y
Latest close: back above its 200-day averageOct 9, 2026what changed →

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though earnings up +14% year on year.

1 good, 2 neutral
Revenue trend+5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +8% a year.

Earnings trend+14% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−0.3 points operating

Trailing-twelve-month operating margin, 64.9% now against 65.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CME growing?

CME Group has grown revenue 9.1% a year over three years and 6.0% a year over five, with earnings per share compounding at 15%.

+9.1%

Revenue growth, 3-year annual rate · Financial Data & Stock Exchanges median +8.1% · steady growth, ahead of inflation · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate
+6.0%

Revenue growth, 5-year rate · +9.1% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
+15%

Earnings per share, 3-year rate · revenue +9.1% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
19

Years of annual history on file · FY2007 to FY2025, as filed

Details›
Revenue FY2021
$4.69B
Revenue FY2022
$5.02B
Revenue FY2023
$5.58B
Revenue FY2024
$6.13B
Revenue FY2025
$6.52B

Annual income statements as filed with the SEC.